Title(s): 

NRG-GU010 Parallel Phase III Randomized Trials of Genomic Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE) (NCT#05050084)
Investigator(s): Ashok Ramalingam, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Referral to: ProstateCancerPromise.org
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Contact Information: McDowell Cancer Research at 330.344.6348